A Comparison of Dry Powder Inhalation Setups Used in Preclinical Testing Mark C. Freke, André Viau. Charles River Montreal, Quebec, Canada 1 ABS TRACT Although it is not critical to use the intended clinical device when generating aerosols as part of a nonclinical testing program, it is crucial that a suitable setup be selected. The generation system has to tick multiple boxes; it has to have the ability to generate not only a range of aerosols sufficient enough to expose the Test System to the multiples of the clinical dose required to prove safety; it has to be able to sustain a stable aerosol at these concentrations for at least the intended duration of dosing; and it has to generate an aerosol that is respirable to the Test System. With the therapeutic agent often being in limited supply during these initial trials, all of these criteria must be met using the most efficient setup and the least amount of material possible. The purpose of this investigation was to directly compare key performance indicators of several routinely used aerosol generation setups and exposure chamber types, namely their ability to achieve a target aerosol, the spatial and temporal homogeneity of the generated aerosol and the mass transfer efficiency (calculated by comparing the amount of powder consumed per minute versus the aerosol concentration generated). 2 MATERIALS AND METHO DS Two dry powder aerosol generation devices were selected, the commercially available PALAS® Rotating Brush Generator (RBG) series 1000 using either 10 mm or 28 mm canisters, and a device developed at Charles River Montreal, referred to internally as the Extended Duration Powder Delivery System, or EDPDS (Figure 1). 3 Aerosols were generated on multiple occasions using Sodium Bicarbonate, USP (Fisher Scientific, lot No. 125296) into cylindrical flow-through or flow-past chambers through a feed line (Bev-A-Line) supplied with pre-dried compressed air. The chambers themselves were of modular design and configured as follows (see Figure 2): The flow-past chamber consisted of an inner and outer plenum that provided 12 separate ports. The aerosol was generated into the central plenum and fed out under slight positive pressure (0.3 L/min) to each port through horizontal delivery branches before being exhausted through the external plenum. The flow-through chamber was effectively a hollow cylinder providing 20 separate ports and was operated under slight negative pressure. Target total aerosol concentrations were achieved by varying the rate of powder introduction into the feed line such that concentrations ranging from 0.1 to 1.0 mg/L could be achieved. Gravimetric sampling techniques (using 25 mm glass fiber filters) were employed to determine the achieved aerosol concentration. Each flow-past and flow-through chamber was sampled over a period of at least 60 minutes, with aerosol concentration means, standard deviations and correlation coefficients calculated along with mass transfer efficiency (MTE) for each. Exhaust rates were sufficient to maintain at least 12 air changes per hour and a chamber environment of 19-25°C, 30-70% RH and at least 19% O2. Monitored as a differential across a constriction in the exhaust line using a Magnehelic® gauge, the exhaust from each chamber was driven by a vacuum pump, drawing contaminated air through a purifying system consisting of a series of filters before expelling the remaining air from the Facility. RE S ULTS 4 CO NCLUSIO NS All setups/combinations had the ability to achieve a homogeneous aerosol concentration at or around 0.1 mg/L, with the EDPDS proving the most efficient dry powder aerosol generation system regardless of chamber type (flow-through versus flow-past) at this concentration (5 to 8% MTE, versus 3 to 4% for the RBG). The RBG, regardless of chamber type, was either not able to achieve, or was not able to maintain, a stable aerosol concentration at the targeted 1.0 mg/L (whereas the EDPDS was). The low mass transfer efficiencies noted during these trials were likely due to the choice of powder used, as it is not uncommon to obtain MTE values of upwards of 70% when using other dry powders such as Lactose Monohydrate, USP using comparable aerosol concentrations and similar equipment setups. Although these values maybe somewhat atypical, they do still allow for a direct comparison within the confines of the investigation. Based on the physical characteristics of the powder being used, careful consideration should be given when selecting a suitable chamber and dry powder aerosol generation system combination for use on preclinical inhalation toxicology programs. Further work is needed to fully understand the relationship between efficiency and aerosol concentration, but under the conditions of this experiment, using Sodium Bicarbonate, USP as test material, it can be concluded that any of the combinations tested are suitable for use when targeting a total dry powder aerosol at or around 0.1 mg/L; with the EDPDS, in combination with either the flow-through or flow-past chamber types, provided the best results (i.e., stable and closest to target) at the higher target aerosol concentration of 1.0 mg/L. Chamber Type Aerosol Generation System EDPDS Flow-through RBG EDPDS Flow-past RBG Figure 1. Left: A PALAS® Rotating Brush Generator (RBG) series 1000 feeding into a flow-past chamber Right: The Charles River-developed/manufactured ‘EDPDS’ Figure 2. Left: Top view of a 12-port flow-past chamber (lid removed). Note sampling line at 10 o’clock Right: A flow-through chamber (note that only one, not three [pictured], exposure levels were used) Target Aerosol conc’n (mg/L) Mean achieved Standard Aerosol Deviation conc’n (mg/L) Correlation Coefficient (%) Variance Mass Transfer from target Efficiency (%) (%) 0.100 0.101 0.0105 10.4 1 5 1.00 0.950 0.1330 14.0 -5 8 0.100 0.091 0.0075 8.2 -9 3 1.00 0.546 0.1401 25.7 -45 3 0.100 0.109 0.0040 3.7 9 8 1.00 0.857 0.1160 13.5 -14 12 0.100 0.099 0.0104 10.5 -1 4 1.00 1.449 0.4732 32.7 45 27 Table 1. Achieved aerosol conditions for each chamber type and powder aerosol generation system combination
© Copyright 2026 Paperzz